Cargando…
Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells
BACKGROUND: Advanced glycation products (AGEs), as endogenous inflammatory mediator, compromise the physiological function of mesenchymal stem cells (MSCs). MSCs have a potential role in cell replacement therapy in acute myocardial infarction and ischemic cardiomyopathy. However, mechanisms of AGEs...
Autores principales: | Yang, Ke, Wang, Xiao Qun, He, Yu Song, Lu, Lin, Chen, Qiu Jing, Liu, Jing, Shen, Wei Feng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987998/ https://www.ncbi.nlm.nih.gov/pubmed/20969783 http://dx.doi.org/10.1186/1475-2840-9-66 |
Ejemplares similares
-
Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells
por: Li, Hong, et al.
Publicado: (2012) -
Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
por: Chen, Jinluan, et al.
Publicado: (2021) -
Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway
por: Qin, Qiaojing, et al.
Publicado: (2013) -
The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs)
por: Li, Zhenyu, et al.
Publicado: (2013) -
The role of autophagy in advanced glycation end product-induced proliferation and migration in rat vascular smooth muscle cells
por: Liu, Zhigang, et al.
Publicado: (2018)